NORWOOD, MA -- (Marketwired) -- 07/27/15 -- (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage pharmaceutical company targeting rare, chronic, and serious inflammatory and fibrotic diseases, announced today it has issued a call notice for the redemption of certain out ...
↧